Skip to content

MiniMed Group MMED Consumables — Net Sales

Other product segments

CGM
$390M+18.2%
Pumps
$151M+11.0%

Similar metrics at other companies

ESAB logo
ESABConsumables — Net Sales
$480.86M+7.9%
10x Genomics, Inc. logo
TXGConsumables — Revenue
$129.8M+12.5%
Dollar Tree logo
DLTRConsumable — Net Sales
$2.49B+6.8%
Illumina logo
ILMNConsumables — Total Revenue
$797M+3.8%
STERIS logo
STEConsumables — Revenue
$456.2M+6.4%
Abbott logo
ABTMedical Devices — Net Sales
$5.54B+13.2%

Other financials

Income statement

See full
Revenue$790.0M+15.0%
Gross profit$362.0M-8.4%
Operating income-$100.0M-576%
Net income-$119.0M-1,090%
EPS (diluted)-$0.47-1,075%

Balance sheet

See full
Cash & equivalents$10.0M0.0%
Total debt$61.0M
Total equity$3.5B-0.7%
Total assets$4.3B

Cash flow

See full
Operating cash flow-$27.0M-147%
CapEx$167.0M+22.8%
Free cash flow-$194.0M-146%

Valuation

See full
Market cap$4.15B
Enterprise value$4.2B

Returns & leverage

See full
Return on equity-4.3%
Debt / equity
Current ratio1.6×

Where this comes from

Reported directly by MiniMed Group in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: MiniMed Group ’s 10-Q, filed April 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiniMed Group 's consumables — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiniMed Group 's consumables — net sales?
MiniMed Group (MMED) reported consumables — net sales of $244M in Q1 2026.
What does consumables — net sales mean?
This metric represents the total revenue generated from the sale of recurring medical supplies, such as infusion sets and sensors, required for the ongoing operation of diabetes management devices. It serves as a key indicator of the company's installed base utilization and long-term customer retention. Growth in this segment reflects the recurring nature of the business model and the sustained engagement of patients with the company's ecosystem.